Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma

被引:14
|
作者
Tunca, F. [1 ]
Sormaz, I. C. [1 ]
Iscan, Y. [2 ]
Senyurek, Y. G. [1 ]
Terzioglu, T. [1 ]
机构
[1] Istanbul Univ, Istanbul Tip Fak Genel Cerrahi Anabilim Dali, Istanbul Fac Med, Dept Gen Surg, TR-34390 Istanbul, Turkey
[2] Fatih Sultan Mehmet Educ & Res Hosp, Dept Gen Surg, Istanbul, Turkey
关键词
Classic and follicular variant papillary thyroid carcinoma; Histopathological features; Prognosis; HISTOLOGIC VASCULAR INVASION; BRAF MUTATION; CLINICOPATHOLOGICAL SIGNIFICANCE; CANCER; POPULATION; SURVIVAL; RISK;
D O I
10.1007/s40618-015-0376-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose To compare the histopathological features and the outcomes of the follicular variant and classical variant of papillary thyroid carcinoma. Material and the methods Demographic data, histopathological features (tumor size, thyroid capsule invasion, extrathyroidal extension, vascular invasion and multicentricity), lymph node metastasis, local recurrence, distant metastasis and mortality during the follow-up of 258 C-PTC and 153 FVPTC patients who underwent total thyroidectomy were compared. The dynamic risk assessment system was used to refine postoperative risk estimates based on the assessment of response to initial treatment. Results The demographic data showed no significant difference between the two groups. The mean tumor size showed no significant difference between the two groups. The rate of thyroid capsule invasion, extrathyroidal extension, and lymph node metastasis was significantly higher in C-PTC than in FVPTC group, whereas multicentricity and bilobar involvement were significantly higher in FVPTC group than in C-PTC group. Central lymph node metastasis was significantly more frequent in patients with C-PTC than in those with FVPTC (p < 0.0001). Local recurrence was found in 22 (5.3 %) patients overall and was significantly more common in C-PTC group than in FVPTC group. In patients >= 45 years, the local recurrence rate was significantly higher in patients with CPTC than in those with FVPTC. The local recurrence rate in patients <45 years was not significantly different between the two groups of patients. The multicentricity rate was significantly higher in the FVPTC group for both age groups. Dynamic risk assessment showed that the rate of intermediate- and high-risk groups showed no significant difference between C-PTC and FVPTC patients but the rate of low risk patients was higher in FVPTC group than in C-PTC group (p = 0.04). The recurrence rate in low-risk group was found higher in C-PTC compared to FVPTC patients (4.7 vs. 0.7 %, p = 0.04, respectively). The recurrence rate showed no significant difference in both intermediate- and high-risk groups in C-PTC and FVPTC patients. During the follow-up, the rate of distant metastasis and disease-specific mortality was not significantly different between the two groups (p = 0.25). Conclusion FVPTC is a common subtype of PTC and has a higher rate of multicentricity with bilobar involvement. Although aggressive histopathologic features, such as thyroid capsule invasion, extrathyroidal extension, and lymph node metastasis, are significantly more frequent in CPTC than in FVPTC, the long-term outcome is similar in both subtypes after appropriate initial surgery and postoperative RAI ablation treatment.
引用
收藏
页码:1327 / 1334
页数:8
相关论文
共 50 条
  • [31] Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma
    Okuyucu, K.
    Alagoz, E.
    Arslan, N.
    Emer, O.
    Ince, S.
    Deveci, S.
    Ayan, A.
    Taslipinar, A.
    Gunalp, B.
    Azal, O.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S369 - S369
  • [32] Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma
    Okuyucu, Kursat
    Alagoz, Engin
    Arslan, Nuri
    Emer, Ozdes
    Ince, Semra
    Deveci, Salih
    Ayan, Asli
    Taslipinar, Abdullah
    Gunalp, Bengul
    Azal, Omer
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (10) : 1021 - 1025
  • [33] Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
    Teng, Lianghong
    Deng, Wanglong
    Lu, Junliang
    Zhang, Jing
    Ren, Xinyu
    Duan, Huanli
    Chuai, Shannon
    Duan, Feidie
    Gao, Wei
    Lu, Tao
    Wu, Huanwen
    Liang, Zhiyong
    [J]. ONCOTARGET, 2017, 8 (13) : 22023 - 22033
  • [34] The diagnostic, dilemma of follicular variant of papillary thyroid carcinoma
    Kesmodel, SB
    Terhune, KP
    Canter, RJ
    Mandel, SJ
    LiVolsi, VA
    Baloch, ZW
    Fraker, DL
    [J]. SURGERY, 2003, 134 (06) : 1005 - 1011
  • [35] Encapsulated follicular variant of papillary thyroid carcinoma - Reply
    Renshaw, A
    Gould, E
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 605 - 606
  • [36] Follicular variant of papillary thyroid carcinoma - a cytological study
    Jogai, S
    Adesina, AO
    Temmim, L
    Al-Jassar, A
    Amir, T
    Amanguno, HG
    [J]. CYTOPATHOLOGY, 2004, 15 (04) : 212 - 216
  • [37] Follicular Variant Papillary Thyroid Carcinoma in a Pediatric Population
    Lerner, Jonathan
    Goldfarb, Melanie
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 (11) : 1942 - 1946
  • [38] Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture?
    Daniels, Gilbert H.
    [J]. THYROID, 2016, 26 (07) : 872 - 874
  • [39] Encapsulated papillary thyroid carcinoma, follicular variant: A misnomer
    Kakudo, Kennichi
    Bai, Yanhua
    Liu, Zhiyan
    Ozaki, Takashi
    [J]. PATHOLOGY INTERNATIONAL, 2012, 62 (03) : 155 - 160
  • [40] Follicular variant of papillary thyroid carcinoma with metastasis to the kidney
    Chrabanska, Magdalena
    Kepinski, Michal
    Drozdzowska, Bogna
    [J]. INDIAN JOURNAL OF CANCER, 2021, 58 (03) : 455 - 457